To Cure or Kill
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
0,99 $/mois pendant vos 3 premiers mois
Exclusivité Prime: 2 titres
gratuits à choisir pendant l'essa. Des conditions s’appliquent.
To Cure or Kill
Acheter pour 31,26 $
Aucun mode de paiement valide enregistré.
Nous sommes désolés. Nous ne pouvons vendre ce titre avec ce mode de paiement
-
Narrateur(s):
-
Michael Young
-
M. D.
-
Auteur(s):
-
Michael Young
À propos de cet audio
The pharmaceutical industry applies evolving scientific knowledge to create new drugs and potential life-saving therapies. Pharmaceutical companies also reap significant financial gains from their drug and therapeutic developments. This monetary incentive could potentially result in aggressive inter-pharmaceutical company espionage.
In this novel, a profiteering pharmaceutical executive seizes upon an opportunity to turn the discovery of a new cancer-preventing drug into a massive industry-competitive advantage for his company and his own personal financial gain. Using ruthless individuals with deadly skills and intent, the executive tries to nefariously obtain the necessary molecular synthesis protocol to create the next generation of oncologic drugs. Through a detailed medical and scientific investigation, doctors, scientists, and law enforcement agencies work together to quickly understand and identify what is occurring in the shadows.
This is a frightening story of scientific discovery versus greed and the quest for money. At the end of the audiobook, the listeners will need to ask themselves the underlying question: Is this story really fiction?
©2023 GMBOOKS (P)2023 GMBOOKS